The Medical Technology Group (MTG) is calling for a new fund for innovative medical devices, following the latest £680 million funding for innovative medicines. The not-for-profit coalition is made up of patient groups, research charities and medical device manufacturers that campaign for better patient access to world-class medical technology on the NHS.
MTG chair Barbara Harpham: “Why is there no scheme, similar to the Innovative Medicines Fund, to ensure long-term investment in medical technology for the NHS? The MTG has long called for better funding of transformative medical device treatments, yet there is still a funding gap for ensuring this on the NHS."
“Last September, the government announced it would aim to provide £36 billion over the next three years for innovation and new technology aimed at tackling the crisis of waiting lists on the NHS. We saw this plan continue to come to fruition this week with the latest round of £680 million in funding for the Innovative Medicines Fund. This is fantastic news for patients on NHS waiting lists awaiting life-saving and life-enhancing treatment. "
According to the MTG, it is estimated that 30 million people in the UK will be diagnosed with long-term health conditions by 2050.
Harpham continued: “We now need a similar Medical Devices Fund for medical technology. At present, there is no ring-fenced funding for the uptake of medical technology, meaning patients are losing out on backlog-busting innovation that will see world-class technology diagnose, treat, and return them to normal life as fast as possible."
“A Medical Devices Fund that values long-term investment will help the Government achieve its ambitious plans to clear the backlog, level up quality of care across the country, and ensure NHS patients have timely and equitable access to the most pioneering medical technology in the world.”